CardioNet Appoints Two Directors to Board
Thursday, August 21, 2008 5:09 PM

Industry veterans bring product marketing and financial expertise to Board

CONSHOHOCKEN, Pa., Aug. 21 /PRNewswire-FirstCall/ -- CardioNet, Inc. (Nasdaq: BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, announced today that it has named Ronald Ahrens and Kirk Gorman to its Board of Directors. The appointments of Mr. Ahrens and Mr. Gorman increase CardioNet's Board to a total of nine members.

Arie Cohen, CardioNet President and CEO, commented, 'Ron and Kirk are tremendous additions to our Board, and we are very pleased and fortunate to have the opportunity to gain from their years of experience across a broad spectrum of healthcare and business disciplines. Their appointments, along with the recent naming of Randy Thurman as Executive Chairman, serve to further strengthen and diversify our Board as we continue to execute our growth strategy and establish CardioNet's mobile cardiac outpatient telemetry system as the best-in-class in the arrhythmia monitoring market.'

A healthcare industry veteran with over forty years of senior executive and management experience, Mr. Ahrens most recently served as President of Merck Consumer Healthcare Group Worldwide. Prior to his tenure at Merck, Mr. Ahrens held several positions within Bristol Myers Squibb, including Consumer Group President North America and President, Bristol Myers Products Division. In addition, Mr. Ahrens has held executive and management positions at Richardson Vicks and Procter & Gamble.

Mr. Ahrens has also established a strong track record on several Boards of Directors. Currently, he serves as a Non-Executive Advisor to the Board of Johnson & Johnson Merck, and is a Board member of Temptime Corporation, a privately held company that supplies vaccine vial monitors, and ULURU, Inc., an AMEX-listed specialty pharmaceutical company specializing in wound care. Previously, Mr. Ahrens was on the Boards of VIASYS Healthcare, Closure Medical Corporation, St. Ives and Alcide.

Mr. Gorman is currently Senior Vice President and Chief Financial Officer of Jefferson Health Systems, the largest hospital system in Philadelphia. Prior to Jefferson Health Systems, he was Senior Vice President and Chief Financial Officer of Universal Health Services, the country's fifth largest investor owned hospital chain, and President, Chief Financial Officer and member of the Board of Trustees of Universal Health Realty Income Trust, a NYSE-listed healthcare REIT. Mr.


Next Page >>
More Options



Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 300 contributors and press releases, SEC filings and full text news from thousands of sources.


 
Rate :  Rate this Commentary  


 Number of Comments (0) Post Comment
 
  
Good Rating(+1)    Bad Rating(-1)
No Data Found

 
Enter Symbol
Enter Search String
Bookmark This Article
Email Article

Send this article by email


Recipient's Name
Recipient's E-mail
Your Name
Your E-mail
Related Quotes

 
  Home | Login |Research | Earnings | Scans | Chat Rooms | Charts | Submit Article | Join Blog Network | Contributors | Subscribe to RSS

copryright 2008 all rights reserved